WT-1 expression in a spectrum of melanocytic lesions: Implication for differential diagnosis

por Chung, Luke S., Man, Yan-gao, Lupton, George P.
Publicado 2010

Functional MRI of Letter Cancellation Task Performance in Older Adults

por Deng, Ivy D., Chung, Luke, Talwar, Natasha, Tam, Fred, Churchill, Nathan W., Schweizer, Tom A., Graham, Simon J.
Publicado 2019

Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab

por Wiendl, Heinz, Carraro, Matthew, Comi, Giancarlo, Izquierdo, Guillermo, Kim, Ho Jin, Sharrack, Basil, Tornatore, Carlo, Daizadeh, Nadia, Chung, Luke, Jacobs, Alan K., Hogan, Richard J., Wychowski, Linda V., Van Wijmeersch, Bart
Publicado 2019

Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies

por Van Wijmeersch, Bart, Singer, Barry A, Boster, Aaron, Broadley, Simon, Fernández, Óscar, Freedman, Mark S, Izquierdo, Guillermo, Lycke, Jan, Pozzilli, Carlo, Sharrack, Basil, Steingo, Brian, Wiendl, Heinz, Wray, Sibyl, Ziemssen, Tjalf, Chung, Luke, Margolin, David H, Thangavelu, Karthinathan, Vermersch, Patrick
Publicado 2019

Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS

por Kuhle, Jens, Daizadeh, Nadia, Benkert, Pascal, Maceski, Aleksandra, Barro, Christian, Michalak, Zuzanna, Sormani, Maria Pia, Godin, Jean, Shankara, Srinivas, Samad, Tarek A, Jacobs, Alan, Chung, Luke, Rӧsch, Nora, Kaiser, Carina, Mitchell, Colin P, Leppert, David, Havari, Evis, Kappos, Ludwig
Publicado 2021

Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of th...

por Bertolotto, Antonio, Arroyo, Rafael, Celius, Elisabeth G., Comi, Giancarlo, Havrdova, Eva Kubala, Honeycutt, William David, Hunter, Samuel F., Izquierdo, Guillermo, Kornek, Barbara, Miller, Tamara, Mitsikostas, Dimos D., Singer, Barry A., Ziemssen, Tjalf, Chung, Luke, Daizadeh, Nadia, Afsar, Salman, Hashemi, Lobat, Senior, Peter
Publicado 2020

Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of th...

por Hunter, Samuel F., Aburashed, Rany A., Alroughani, Raed, Chan, Andrew, Dive, Dominique, Eichau, Sara, Kantor, Daniel, Kim, Ho Jin, Lycke, Jan, Macdonell, Richard A. L., Pozzilli, Carlo, Scott, Thomas, Sharrack, Basil, Wiendl, Heinz, Chung, Luke, Daizadeh, Nadia, Baker, Darren P., Vermersch, Patrick
Publicado 2021